Who is affected by this change?

This affects Independence Blue Cross ENT (Ear, Nose & Throat) providers on Medicare Advantage plans.

When does this change take effect?

This change is effective Jul 1, 2025.

Back to dashboard

Medicare AdvantageCoverageMedium impact

MA11.049h, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids

Independence Blue Cross·ENT (Ear, Nose & Throat)·Medical Policy

Effective date

Jul 1, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA11.049h regarding bone-anchored (osseointegrated) hearing aids and implantable middle ear hearing aids has been updated. This policy affects coverage and billing for specialized hearing device procedures and implants.

Action Required

Action needed

By July 1, 2025: Billing team should review the updated MA11.049h policy for bone-anchored hearing aids and implantable middle ear hearing devices. Verify current authorization requirements and coverage criteria for Medicare Advantage patients requiring these devices. Contact payer for specific billing guidelines if treating patients with hearing aid implants.

Related policy hubs

Independence Blue Cross policies ENT (Ear, Nose & Throat)